Skip to content
  • Home
    • Journal information
    • Editorial board
    • Operations manual
    • Editorial policies
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • TOC Alert
    • Current issue
  • Information
    • Editorial & Peer Review
    • Ethical policies
    • Funding
    • Complaints and appeals
    • Open access and licensing
    • Authors
    • Sponsorship
    • Contact
  • Publish
    • Instructions to authors
    • Online submission
  • Español
  • English
  • Home
    • Journal Information
    • Editorial Board
    • Operations Manual
    • Editorial Polices
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • Toc Alert
    • Current issue
  • Information
    • Editorial & Peer review
    • Ethical policies
    • Funding
    • Procedure for complaints and/or appeals
    • Open access & Licensing
    • Authors
    • Sponsors
    • Contact
  • Publish
    • Authors Instructions
    • Online submission
  • Home
    • Journal Information
    • Editorial Board
    • Operations Manual
    • Editorial Polices
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • Toc Alert
    • Current issue
  • Information
    • Editorial & Peer review
    • Ethical policies
    • Funding
    • Procedure for complaints and/or appeals
    • Open access & Licensing
    • Authors
    • Sponsors
    • Contact
  • Publish
    • Authors Instructions
    • Online submission
  • ES
  • EN
  • TOC Alert

Day: 4 February 2026

Metabolic dysfunction associated steatotic liver disease: the new mapping of a silent disease

Content available only in Spanish.

Importance of the new steatotic liver disease nomenclature

Content available only in Spanish.

Epidemiology of metabolic hepatic steatosis

Content available only in Spanish.

Pathophysiology of metabolic dysfunction associated steatotic liver disease

Content available only in Spanish.

Endocrine aspects beyond insulin resistance in metabolic dysfunction associated steatotic liver disease

Content available only in Spanish.

Metabolic comorbidity in metabolic dysfunction associated steatotic liver disease

Content available only in Spanish.

Cardiovascular risk in metabolic dysfunction associated steatotic liver disease

Content available only in Spanish.

Initial evaluation of the patient with metabolic dysfunction–associated steatotic liver disease

Content available only in Spanish.

Alcohol and metabolic dysfunction interaction: MetALD

Content available only in Spanish.

Metabolic hepatic steatosis and hepatocellular carcinoma

Content available only in Spanish.

Next →
PERMANYER
  • permanyer@permanyer.com
  • www.permanyer.com

Mallorca, 310
08037 Barcelona (España)

Arquímedes, 190 – Colonia Polanco
Delegación Miguel Hidalgo
11560 Ciudad de México (México)

RECURRING LINKS
  • Current Issue
  • Ahead of Print
  • Archive
  • Online submission
  • Contact
CLOCKSS is a dak archive that ensures the long-term survival of web-based scholary publications, governed by and for its stakeholders.

Esta revista se adhiere a los principios establecidos por el Committee on Publication Ethics

Visitors: 11,694

  • Copyright 2025
  • Legal Notice
  • Permissions & Reprints
  • Data Protection Policy
  • Ethics Code
  • Conflicts of Interest